Appatinib Combined With S-1 in the Treatment of Small Cell Lung Cancer
NCT04128800
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Small Cell Lung Cancer
Interventions
DRUG:
Apatinib S-1
Sponsor
Tianjin Medical University Cancer Institute and Hospital